Oncology Medical News about NSCLC;clinicopathological features;epigenetic inactivation;Homeobox A5 gene

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features
Molecular Carcinogenesis, 06/30/09

Kim DS et al. - In a trial to explore the role of Homeobox A5 (HOXA5) in non-small cell lung cancer (NSCLC), it was shown that downregulation of the HOXA5 gene by aberrant promoter methylation occurs in the vast majority of NSCLCs and it may play a role in the pathogenesis of NSCLC.

Methods

Methylation status of the promoter region of the HOXA5 gene was investigated in NSCLCs using nested and standard methylation-specific PCR (MSP).
Methylation status with clinicopathological features was correlated.

Results

With standard MSP analysis, HOXA5 methylation was found in 113 (81.3%) of 139 NSCLCs and 72 (51.8%) in their corresponding nonmalignant lung tissues.
RT-PCR and immunohistochemical analysis showed that HOXA5 methylation correlates with gene expression.
In pts with stage I disease, HOXA5 methylation was more frequent in smokers than in never-smokes.
There was no influence of HOXA5 methylation on survival in all NSCLCs or at stages II-IV.
In patients with stage I disease, HOXA5 methylation was associated with a borderline significantly worse survival.

<< Previous
Abdominal complications of chemotherapy in pediatric...

Next >>
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in...

Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09 Relevance Score: 89%

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09 Relevance Score: 87%

Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
Journal of Clinical Oncology, 10/29/09 Relevance Score: 85%

Expression and Significance of Clusterin in Anip973/CDDP Cell Lines
Chinese Journal of Lung Cancer, 10/23/09 Relevance Score: 85%

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
British Journal of Cancer, 10/19/09 Relevance Score: 85%